STIM Stock Analysis: Buy, Sell, or Hold?
STIM - Neuronetics, Inc. Common Stock
$1.22
-0.06 (-4.69%)
▼
5d:
-18.94%
30d:
-14.08%
90d:
-14.69%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When STIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: STIM is down 18.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: STIM is down 18.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: STIM is currently trading at $1.22, which is considered oversold relative to its 30-day fair value range of $1.37 to $1.84.
Technical Outlook: Technically, STIM is in a downtrend. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.33 (+238.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, STIM is in a downtrend. The price is currently testing key support at $1.25. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.33 (+238.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.37 -
$1.84
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.7%)
- BULLISH: Trading 238.5% below Wall St target ($4.33)
- WARNING: Recommendation downgraded due to -18.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.37 -
$1.84
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.25
Resistance Level
$2.48
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.22
Wall Street Target
$4.33
(+238.5%)
Revenue Growth (YoY)
7.8%
Profit Margin
-24.5%
Share & Embed Analysis
Last updated: May 18, 2026 10:03 AM ET
Data refreshes hourly during market hours. Next update: 11:03 AM
Data refreshes hourly during market hours. Next update: 11:03 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STIM showing a specific setup today?
Insider Activity (6 Months)
5
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Jorey Chernett
BUY
100000 shares
2026-04-20
Jorey Chernett
BUY
169472 shares
2026-03-20
Jorey Chernett
BUY
450000 shares
2026-03-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 59 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 55 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
